TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors

With recent progress in understanding the pathogenesis of adrenocortical tumors (ACTs), identification of molecular markers to predict their prognosis has become possible. Transcription factor 21 (TCF21)/podocyte-expressed 1 (POD1) is a transcriptional regulatory protein expressed in mesenchymal cel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Passaia, Barbara dos Santos, Dias, Matheus Henrique, Kremer, Jean Lucas, Antonini, Sonir Roberto Rauber, de Almeida, Madson Queiroz, Fragoso, Maria Candida Barisson Villares, Lotfi, Claudimara Ferini Pacicco
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827685/
https://ncbi.nlm.nih.gov/pubmed/29520253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars